Target intelligence / Profile preview

Cell membranes and reactive oxygen species in ocular tissues

Molecular classification
Other
01

Overview

Cell membranes and reactive oxygen species (ROS) in ocular tissues refers to the physiological and pathological interaction between highly reactive oxygen-containing molecules and the lipid bilayers of cells within the eye, including the retina, lens, and cornea. ROS, such as superoxide and hydrogen peroxide, are generated as byproducts of mitochondrial metabolism or induced by external stressors like ultraviolet (UV) radiation and high oxygen tension (Nita & Grzybowski, 2016). When the production of ROS exceeds the capacity of the eye's endogenous antioxidant defenses, oxidative stress occurs, leading to the peroxidation of polyunsaturated fatty acids in cell membranes, which compromises structural integrity and leads to cell death (Gaschler & Stockwell, 2017). This oxidative damage is a primary driver in the pathogenesis of major ocular diseases, including age-related macular degeneration (AMD), cataracts, and glaucoma (Beatty et al., 2000). Therapeutic strategies, such as the AREDS2 formulation, utilize antioxidants like lutein and zeaxanthin to scavenge ROS and mitigate membrane damage (Chew et al., 2013). Because this term describes a broad pathological environment and a set of chemical interactions rather than a single protein or receptor, it is classified as a biological process rather than a discrete molecular target.

Other names
Ocular oxidative stressLipid peroxidation in the eyeROS-mediated ocular damageOcular redox imbalance
02

Mechanism of action

Neutralization of free radicals (radical scavenging), inhibition of lipid peroxidation, and enhancement of endogenous antioxidant enzyme activity to protect ocular cell membranes from structural damage.

03

Biological functions

Oxidative stressLipid peroxidationCellular homeostasisApoptosisSignal transduction
04

Disease associations

Age-related macular degenerationCataractGlaucomaDiabetic retinopathyDry eye syndromeUveitis
05

Safety considerations

Potential pro-oxidant activity at high concentrationsInterference with essential physiological ROS signalingLimited ocular bioavailability of systemic antioxidantsRisk of lung cancer in smokers with high-dose beta-carotene (historical AREDS concern)
06

Interacting drugs

Lutein

7 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione (GSH) levelsF2-isoprostanesSuperoxide dismutase (SOD) activity

Beyond the preview

Go deeper on Cell membranes and reactive oxygen species in ocular tissues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell membranes and reactive oxygen species in ocular tissues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call